Literature DB >> 15231555

Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial.

Judith Proudfoot1, Clash Ryden, Brian Everitt, David A Shapiro, David Goldberg, Anthony Mann, Andre Tylee, Isaac Marks, Jeffrey A Gray.   

Abstract

BACKGROUND: Preliminary results have demonstrated the clinical efficacy of computerised cognitive-behavioural therapy (CBT) in the treatment of anxiety and depression in primary care. AIMS: To determine, in an expanded sample, the dependence of the efficacy of this therapy upon clinical and demographic variables.
METHOD: A sample of 274 patients with anxiety and/or depression were randomly allocated to receive, with or without medication, computerised CBT or treatment as usual, with follow-up assessment at 6 months.
RESULTS: The computerised therapy improved depression, negative attributional style, work and social adjustment, without interaction with drug treatment, duration of preexisting illness or severity of existing illness. For anxiety and positive attributional style, treatment interacted with severity such that computerised therapy did better than usual treatment for more disturbed patients. Computerised therapy also led to greater satisfaction with treatment.
CONCLUSIONS: Computer-delivered CBT is a widely applicable treatment for anxiety and/or depression in general practice.

Entities:  

Mesh:

Year:  2004        PMID: 15231555     DOI: 10.1192/bjp.185.1.46

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  104 in total

Review 1.  Computerised cognitive behavioural therapy for the prevention and treatment of depression and anxiety in children and adolescents: a systematic review.

Authors:  Thomas Richardson; Paul Stallard; Sophie Velleman
Journal:  Clin Child Fam Psychol Rev       Date:  2010-09

2.  Comparative, clinical feasibility study of three tools for delivery of cognitive behavioural therapy for mild to moderate depression and anxiety provided on a self-help basis.

Authors:  Sarah Pittaway; Caroline Cupitt; David Palmer; Nike Arowobusoye; Ross Milne; Sue Holttum; Robert Pezet; Hannah Patrick
Journal:  Ment Health Fam Med       Date:  2009-09

3.  The heterogeneity of "major depression".

Authors:  David Goldberg
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

Review 4.  Computer-assisted cognitive-behavioral therapy.

Authors:  Joyce A Spurgeon; Jesse H Wright
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

Review 5.  Internet-delivered cognitive behavioural therapy in the treatment of psychiatric illness.

Authors:  David Gratzer; Faiza Khalid-Khan
Journal:  CMAJ       Date:  2015-11-02       Impact factor: 8.262

6.  Feasibility study of an interactive multimedia electronic problem solving treatment program for depression: a preliminary uncontrolled trial.

Authors:  Margit I Berman; Jay C Buckey; Jay G Hull; Eftihia Linardatos; Sueyoung L Song; Robert K McLellan; Mark T Hegel
Journal:  Behav Ther       Date:  2014-02-07

7.  Managing depression in primary care.

Authors:  Andre Tylee; Roger Jones
Journal:  BMJ       Date:  2005-04-09

8.  Participatory medicine: model based tools for engaging and empowering the individual.

Authors:  Mark Sagar; Elizabeth Broadbent
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

Review 9.  Treatment of Depression in Primary Care with Computerized Psychological Therapies: Systematic Reviews.

Authors:  Francisco Rodriguez-Pulido; Gema Castillo; Sofiane Hamrioui; Laura Delgado Martin; Pilar Vazquez-Beltrán; Isabel de la Torre-Díez; Manuel A Franco-Martín
Journal:  J Med Syst       Date:  2020-02-13       Impact factor: 4.460

10.  Brief cognitive behavioral therapy compared to general practitioners care for depression in primary care: a randomized trial.

Authors:  Kim D Baas; Maarten W J Koeter; Henk C van Weert; Peter Lucassen; Claudi L H Bockting; Karin A Wittkampf; Aart H Schene
Journal:  Trials       Date:  2010-10-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.